GL
GlenmarkPharm2%220628S
4G8B
General Announcement::GPL Announces Encouraging Phase 1 Results Supporting Biosimilarity Criteria for GBR 310
Original SGX announcement
Read the archived filing
Membership includes the on-site filing reader and available attachments.
SGD 5 / month
Billed automatically. Cancel any time.
Sign in to subscribeWhat membership includes
- Full recorded dividend history
- Archived SGX filing details and available attachments
- Ad-free browsing